MARKET

CODX

CODX

Co-Diagnostics Inc
NASDAQ
1.160
+0.010
+0.87%
Opening 14:32 04/24 EDT
OPEN
1.140
PREV CLOSE
1.150
HIGH
1.180
LOW
1.130
VOLUME
31.40K
TURNOVER
0
52 WEEK HIGH
1.890
52 WEEK LOW
0.9750
MARKET CAP
36.26M
P/E (TTM)
-0.9635
1D
5D
1M
3M
1Y
5Y
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan
Co-Diagnostics, Inc. Will be hosting a booth at the 9th Asia Pacific Region Conference on April 26-29, 2024 in Taipei, Taiwan. Co-Dx is a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests.
Barchart · 10h ago
Weekly Report: what happened at CODX last week (0415-0419)?
Weekly Report · 2d ago
Elevance Health (ELV) Beats Q1 Earnings Estimates
NASDAQ · 6d ago
Weekly Report: what happened at CODX last week (0408-0412)?
Weekly Report · 04/15 12:00
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
Ribbon-cutting included support from Mayor Wood of South Salt Lake and other dignitaries. Co-Diagnostics, Inc. Held the ribbon cutting event for its new manufacturing facility in the City of Salt Lake. The facility has been designed to manufacture the Co-Dx Pro™ instrument and test cups for the new platform.
Barchart · 04/12 08:30
Weekly Report: what happened at CODX last week (0401-0405)?
Weekly Report · 04/08 12:07
Co-Diagnostics, Inc. Appoints Richard Abbott As President, Concurrent With The Co Naming David Nielsen To Be Its Chief Operations Officer
Co-Diagnostics, Inc. Named Richard Abbott as President of the company. Co-Dx has a unique, patented platform for the development of molecular diagnostic tests. The Company also named David Nielsen, Christopher Thurston, and Seth Egan to key positions.
Benzinga · 04/04 13:31
*Co-Diagnostics Names David Nielsen as Chief Ops Officer and Christopher Thurston as Chief Technology Officer >CODX
Dow Jones · 04/04 13:31
More
About CODX
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Webull offers Co-Diagnostics Inc stock information, including NASDAQ: CODX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CODX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CODX stock methods without spending real money on the virtual paper trading platform.